Literature DB >> 30733087

A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs.

Lulu Zhao1, Xinyu Yuan1, Jubo Wang1, Yifan Feng1, Fei Ji1, Zhiyu Li2, Jinlei Bian3.   

Abstract

Protein kinases have been important targets for antitumor targets due to their key roles in regulating multiple cell signaling pathways. Numerous compounds containing flavonoid scaffold as an indispensable anchor have been found to be potent inhibitors of protein kinases. Some of these flavonoids have been in clinical research as protein kinases inhibitors. Thus, the present review mainly focuses on the structural requirement for anticancer potential of flavone derivatives targeting several key serine/threonine protein kinases. This information may provide an opportunity to scientists of medicinal chemistry to design multi-functional flavone derivatives for the treatment of cancer.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Binding mode; Cancer; Flavonoids; Protein kinase; Structure-activity relationship

Mesh:

Substances:

Year:  2019        PMID: 30733087     DOI: 10.1016/j.bmc.2019.01.027

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  Phytochemistry, biological activities and in silico molecular docking studies of Oxalis pes-caprae L. compounds against SARS-CoV-2.

Authors:  Farhat Gul; Ilham Khan; Javed Iqbal; Banzeer Ahsan Abbasi; Amir Shahbaz; Raffaele Capasso; Itzel Amaro-Estrada; Yousef A Bin Jardan; Raquel Cossio-Bayugar; Tariq Mahmood
Journal:  J King Saud Univ Sci       Date:  2022-05-30

Review 2.  Flavonoids: structure-function and mechanisms of action and opportunities for drug development.

Authors:  Stephen Safe; Arul Jayaraman; Robert S Chapkin; Marcell Howard; Kumaravel Mohankumar; Rupesh Shrestha
Journal:  Toxicol Res       Date:  2021-01-20

3.  Diamond Blackfan anemia is mediated by hyperactive Nemo-like kinase.

Authors:  M C Wilkes; K Siva; J Chen; G Varetti; M Y Youn; H Chae; F Ek; R Olsson; T Lundbäck; D P Dever; T Nishimura; A Narla; B Glader; H Nakauchi; M H Porteus; C E Repellin; H T Gazda; S Lin; M Serrano; J Flygare; K M Sakamoto
Journal:  Nat Commun       Date:  2020-07-03       Impact factor: 14.919

Review 4.  Important Flavonoids and Their Role as a Therapeutic Agent.

Authors:  Asad Ullah; Sidra Munir; Syed Lal Badshah; Noreen Khan; Lubna Ghani; Benjamin Gabriel Poulson; Abdul-Hamid Emwas; Mariusz Jaremko
Journal:  Molecules       Date:  2020-11-11       Impact factor: 4.411

5.  Antimicrobial, Anticancer and Multidrug-Resistant Reversing Activity of Novel Oxygen-, Sulfur- and Selenoflavones and Bioisosteric Analogues.

Authors:  Małgorzata Anna Marć; Annamária Kincses; Bálint Rácz; Muhammad Jawad Nasim; Muhammad Sarfraz; Carlos Lázaro-Milla; Enrique Domínguez-Álvarez; Claus Jacob; Gabriella Spengler; Pedro Almendros
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-11

6.  Effects of Annurca Flesh Apple Polyphenols in Human Thyroid Cancer Cell Lines.

Authors:  Francesca Maria Orlandella; Peppino Mirabelli; Anna Elisa De Stefano; Paola Lucia Chiara Iervolino; Neila Luciano; Stefania D'Angelo; Giuliana Salvatore
Journal:  Oxid Med Cell Longev       Date:  2022-02-17       Impact factor: 6.543

7.  Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling.

Authors:  Jing-Yue Yao; Shu Xu; Yue-Ning Sun; Ye Xu; Qing-Long Guo; Li-Bin Wei
Journal:  Acta Pharmacol Sin       Date:  2021-06-29       Impact factor: 6.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.